Rouprêt M - Search Results

1

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).

Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Dominguez Escrig JL, Gontero P, Liedberg F, Masson-Lecomte A, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Seisen T, Soukup V, Sylvester RJ. Babjuk M, et al. Among authors: roupret m. Eur Urol. 2022 Jan;81(1):75-94. doi: 10.1016/j.eururo.2021.08.010. Epub 2021 Sep 10. Eur Urol. 2022. PMID: 34511303 Review.

2

Is there a place for radical nephrectomy in the presence of metastatic collecting duct (Bellini) carcinoma?

Méjean A, Rouprêt M, Larousserie F, Hopirtean V, Thiounn N, Dufour B. Méjean A, et al. Among authors: roupret m. J Urol. 2003 Apr;169(4):1287-90. doi: 10.1097/01.ju.0000050221.51509.f5. J Urol. 2003. PMID: 12629344

3

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.

Rouprêt M, Fromont G, Azzouzi AR, Catto JW, Vallancien G, Hamdy FC, Cussenot O. Rouprêt M, et al. Urology. 2005 Jun;65(6):1233-7. doi: 10.1016/j.urology.2005.01.019. Urology. 2005. PMID: 15922421

4

Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.

Fromont G, Rouprêt M, Amira N, Sibony M, Vallancien G, Validire P, Cussenot O. Fromont G, et al. Among authors: roupret m. Eur Urol. 2005 Nov;48(5):764-70. doi: 10.1016/j.eururo.2005.07.005. Epub 2005 Aug 1. Eur Urol. 2005. PMID: 16126329

5

Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection.

Rouprêt M, Traxer O, Tligui M, Conort P, Chartier-Kastler E, Richard F, Cussenot O. Rouprêt M, et al. Eur Urol. 2007 Mar;51(3):709-13; discussion 714. doi: 10.1016/j.eururo.2006.07.019. Epub 2006 Jul 28. Eur Urol. 2007. PMID: 16911852

6

[Bladder cancer and neurogenic bladder].

Ruffion A, Comperat E, Roupret M, Chartier-Kastler E. Ruffion A, et al. Among authors: roupret m. Prog Urol. 2007 May;17(3):431-5. doi: 10.1016/s1166-7087(07)92342-8. Prog Urol. 2007. PMID: 17622071 French.

7

Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract.

Compérat E, Roupret M, Chartier-Kastler E, Bitker MO, Richard F, Camparo P, Capron F, Cussenot O. Compérat E, et al. Among authors: roupret m. J Urol. 2008 Mar;179(3):868-72; discussion 872. doi: 10.1016/j.juro.2007.10.079. Epub 2008 Jan 25. J Urol. 2008. PMID: 18221954

8

[Bladder cancer in neurological patients: analysis of a single-centre series].

Parra J, Drouin S, Comperat E, Misraï V, Van Glabeke E, Richard F, Denys P, Chartier-Kastler E, Rouprêt M. Parra J, et al. Among authors: roupret m. Prog Urol. 2007 Nov;17(7):1333-6. doi: 10.1016/s1166-7087(07)78572-x. Prog Urol. 2007. PMID: 18271417 French.

9

[Can a standard treatment be proposed for penile cancer?].

Cornu JN, Comperat E, Renard-Penna R, Misrai V, Bitker MO, Haertig A, Chartier-Kastler E, Richard F, Roupret M. Cornu JN, et al. Among authors: roupret m. Prog Urol. 2007 Nov;17(7):1347-50. doi: 10.1016/s1166-7087(07)78575-5. Prog Urol. 2007. PMID: 18271420 French.

10

A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.

Rouprêt M, Hupertan V, Yates DR, Comperat E, Catto JW, Meuth M, Lackmichi A, Ricci S, Lacave R, Gattegno B, Richard F, Hamdy FC, Cussenot O. Rouprêt M, et al. BJU Int. 2008 Jun;101(11):1448-53. doi: 10.1111/j.1464-410X.2008.07591.x. Epub 2008 Mar 4. BJU Int. 2008. PMID: 18325051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,014 results

Search Page